Boston Scientific (BSX) Free Cash Flow Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -14.34% |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | 19.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.29% |
| Mar 31, 2026 | -51.69% |
| Dec 31, 2025 | -14.08% |
| Sep 30, 2025 | 41.19% |
| Jun 30, 2025 | 71.58% |
| Mar 31, 2025 | 2,460.00% |
| Dec 31, 2024 | 70.87% |
| Sep 30, 2024 | 62.01% |
| Jun 30, 2024 | 27.77% |
| Mar 31, 2024 | -118.99% |
| Dec 31, 2023 | 15.97% |
| Sep 30, 2023 | 58.75% |
| Jun 30, 2023 | 154.95% |
| Mar 31, 2023 | 144.13% |
| Dec 31, 2022 | 180.66% |
| Sep 30, 2022 | -10.61% |
| Jun 30, 2022 | -62.38% |
| Mar 31, 2022 | -185.65% |
| Dec 31, 2021 | -58.75% |
| Sep 30, 2021 | -39.73% |